These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7954353)

  • 21. Calcium leucovorin and 5-fluorouridine cytotoxicity.
    Berger SH; Hakala MT
    J S C Med Assoc; 1990 May; 86(5):284-9. PubMed ID: 2242115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH; Tan YY; Cadman EC; Armstrong RD
    Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
    Pawlikowski M; Kunert-Radek J; Winczyk K
    Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro translation of messenger RNA following exposure of human colon carcinoma cells in culture to 5-fluorouracil and 5-fluorouridine.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1983 Mar; 23(2):540-6. PubMed ID: 6835205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.
    Inaba M; Mitsuhashi J
    Oncol Res; 1994; 6(7):303-9. PubMed ID: 7865905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-directed actions of 5-fluorouridine in hemin stimulated K-562 erythroleukemia cells.
    Heimer R; Sartorelli AC
    Cancer Biochem Biophys; 1992 May; 12(4):221-39. PubMed ID: 1423209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
    Benz C; Cadman E
    Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
    Schwartz PM; Moir RD; Hyde CM; Turek PJ; Handschumacher RE
    Biochem Pharmacol; 1985 Oct; 34(19):3585-9. PubMed ID: 2996553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
    Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
    Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.
    Benz C; Santos G; Cadman E
    Cancer Res; 1983 Nov; 43(11):5304-8. PubMed ID: 6616465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M; Glazer RI
    Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.
    Wolf W; Presant CA; Servis KL; el-Tahtawy A; Albright MJ; Barker PB; Ring R; Atkinson D; Ong R; King M
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):492-6. PubMed ID: 2296605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
    Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
    Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
    Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.